Site-Specific Glycosylation Using Pichia Expression System Improves Structural Stability And Antimicrobial Activity Of Human Cystatin C

Soichiro Nakamura,Junya Hata,Kosuke Nakamura,Hao Jing,David D. Kitts,Shuryo Nakai
2010-01-01
Abstract:Human cystatin C (HCC) was subjected to site-specific substitution of alanine for serine at the position 37 by the mutated Asn(35)-Lys(36)-Ser(37) sequence transformed into Pichia pastoris X33. The sequence is a signal for asparagine-linked (N-linked) glycosylation of protein in eukaryotes. More than 1 mg L-1 oligomannosyl HCC with a carbohydrate chain of Man(10)GlcNAc(2) was produced by the Pichia transformant. The oligomannosyl HCC was more stable than the wild-type at the low ionic strength condition of 50 mM potassium phosphate buffer (pH 7.0). Furthermore, the oligomannosylation significantly improved the molecular stability of cystatin against an aspartic proteinase, cathepsin D, with the susceptibility decreased to less than 50% of nonglycosylated one. The anti-rotavirus activity of HCC was significantly enhanced by the site-directed glycosylation. MA-104 and CV-1 cells were used as host cells for rotavirus type-2 Wa and Salmonella enteritidis, respectively. Both the wild-type and oligomannosyl HCC's showed no significant cytotoxicity at the test concentration of 100 mu g mL(-1). More than 80 % viability of the host cell infected with 1.0 x 10(5) mL(-1) of rotavirus was conserved when coexisting with 75 mu g mL(-1) of the oligomannosyl HCC, which was 15.2 % higher than that of wild-type HCC. In addition, 100 mu g mL(-1) of the oligomannosyl inhibitor prevented 80% of the invasion of Salmonella into the host cells. These results indicated that the oligomannosyl HCC could be used as a stable and bioactive agent against rotavirus and Salmonella
What problem does this paper attempt to address?